These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14508854)

  • 21. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
    Saji H; Nakamura H; Awut I; Kawasaki N; Hagiwara M; Ogata A; Hosaka M; Saijo T; Kato Y; Kato H
    Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):295-300. PubMed ID: 14672525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
    Socinski MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancer.
    Grossi F; Gridelli C; Aita M; De Marinis F
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):16-26. PubMed ID: 18243728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics in non-small-cell lung cancer chemotherapy.
    Danesi R; Pasqualetti G; Giovannetti E; Crea F; Altavilla G; Del Tacca M; Rosell R
    Adv Drug Deliv Rev; 2009 May; 61(5):408-17. PubMed ID: 19292993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
    Massion PP; Carbone DP
    Respir Res; 2003; 4(1):12. PubMed ID: 14641911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.
    Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2008 Mar; 9(2):78-84. PubMed ID: 18501093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
    Ausborn NL; Le QT; Bradley JD; Choy H; Dicker AP; Saha D; Simko J; Story MD; Torossian A; Lu B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e453-64. PubMed ID: 22520478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study.
    Gobitti C; Franchin G; Minatel E; Gigante M; Basso B; Bujor L; Trovò MG
    Oncol Rep; 2005 Dec; 14(6):1647-53. PubMed ID: 16273271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular predictors of chemotherapy response in non-small-cell lung cancer.
    Gray J; Simon G; Bepler G
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):545-9. PubMed ID: 17428174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
    Jiang F; Caraway NP; Nebiyou Bekele B; Zhang HZ; Khanna A; Wang H; Li R; Fernandez RL; Zaidi TM; Johnston DA; Katz RL
    Clin Cancer Res; 2005 Aug; 11(15):5417-24. PubMed ID: 16061856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation and nonsmall cell lung cancer.
    Lu F; Zhang HT
    Anat Rec (Hoboken); 2011 Nov; 294(11):1787-95. PubMed ID: 21956844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival improvement in thoracic cancer: progress from the last decade and beyond.
    Manegold C; Thatcher N
    Lung Cancer; 2007 Aug; 57 Suppl 2():S3-5. PubMed ID: 17686443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of EGFR mutation analysis in non-small cell lung cancer.
    Yamamoto H; Toyooka S; Mitsudomi T
    Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biology of lung cancer.
    Carney DN
    Curr Opin Pulm Med; 1995 Jul; 1(4):271-7. PubMed ID: 9363064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis.
    Maldonado F; Jett JR
    Curr Opin Pulm Med; 2010 Jul; 16(4):315-20. PubMed ID: 20173641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.